CLINICAL_TRIALS
withdrawal
· 2022-08-30
Clinical Trial Update: Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Summary
A Phase 4 trial evaluating appropriate inhaler use in COPD has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: WITHDRAWN